A58 Stock Overview
Operates as a health benefits company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Elevance Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$371.80 |
| 52 Week High | US$506.20 |
| 52 Week Low | US$371.80 |
| Beta | 0.85 |
| 11 Month Change | -5.99% |
| 3 Month Change | -23.39% |
| 1 Year Change | -13.53% |
| 33 Year Change | -0.29% |
| 5 Year Change | 41.80% |
| Change since IPO | 296.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| A58 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -4.1% | -0.3% | -0.4% |
| 1Y | -13.5% | 14.5% | 7.1% |
Return vs Industry: A58 underperformed the German Healthcare industry which returned 17.2% over the past year.
Return vs Market: A58 underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| A58 volatility | |
|---|---|
| A58 Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: A58 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: A58's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
| A58 fundamental statistics | |
|---|---|
| Market cap | €86.74b |
| Earnings (TTM) | €6.09b |
| Revenue (TTM) | €165.11b |
14.4x
P/E Ratio0.5x
P/S RatioIs A58 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A58 income statement (TTM) | |
|---|---|
| Revenue | US$174.02b |
| Cost of Revenue | US$125.40b |
| Gross Profit | US$48.61b |
| Other Expenses | US$42.20b |
| Earnings | US$6.42b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 27.67 |
| Gross Margin | 27.94% |
| Net Profit Margin | 3.69% |
| Debt/Equity Ratio | 61.9% |
How did A58 perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield23%
Payout RatioDoes A58 pay a reliable dividends?
See A58 dividend history and benchmarks| Elevance Health dividend dates | |
|---|---|
| Ex Dividend Date | Dec 05 2024 |
| Dividend Pay Date | Dec 20 2024 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 28 days |
Does A58 pay a reliable dividends?
See A58 dividend history and benchmarks